GlassScriptPhysician profile
Jonah S Bergman
NPI 1356439624
$11,565.63
in general payments reported to CMS, 2019-2025
20 companies · $1,463 in 2025
The $1,463 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,128 · 2020: $701 · 2021: $997 · 2022: $1,456 · 2023: $1,883 · 2024: $1,936 · 2025: $1,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,282.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,795.82 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $1,856.78 | 2019-2025 | Cequa, Xelpros |
| Bausch & Lomb Americas INC. | $1,013.88 | 2022-2025 | Miebo, Envista Mx60 Iol, Xiidra |
| Johnson & Johnson Vision Care, INC. | $994.56 | 2021-2025 | Acuvue |
| Oyster Point Pharma, INC. | $979.07 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Alcon Vision LLC | $625.88 | 2020-2025 | Tryptyr, Rocklatan, Eysuvis |
| Allergan, INC. | $534.34 | 2019-2022 | |
| Abbvie INC. | $528.46 | 2022-2025 | Durysta, Lumigan |
| Johnson & Johnson Surgical Vision, INC. | $405.71 | 2021-2025 | Tecnis Iol, Catalys System, Tecnis Iol |
| Amgen INC. | $375.54 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $351.07 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $251.67 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $242.92 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $173.15 | 2019 | |
| Shire North American Group INC | $144.84 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $143.57 | 2024-2025 | Vevye |
| Thea Pharma INC. | $95.19 | 2023-2025 | Iyuzeh |
| Glaukos Corporation | $26.14 | 2019 | |
| Sight Sciences, INC. | $15.27 | 2022 | |
| Rxsight INC | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonah Bergman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.